A 54 year old man presents to the Emergency Department following an accidental overdose of paracetamol, taken for dental pain. His LFTs are deranged and the n-acetylcysteine (NAC) infusion is initiated. After approximately 30 minutes the patient becomes flushed and tachycardic. How should this situation be managed in the first instance?
Paracetamol is usually conjugated in the liver to inactive substances. A small amount is metabolised by the cytochrome P450 system producing a toxic metabolite N-acetyl-p-benzoquinoneimine (NAPQI), which is then inactivated by conjugation with glutathione. In paracetamol overdose, the normal pathway of conjugation is saturated and a greater proportion of paracetamol is metabolised by the cytochrome P450 system. Once the reserves of glutathione are depleted, the toxic metabolite NAPQI builds up and causes hepatic necrosis.
All patients who meet any of the following criteria should be referred to hospital for medical assessment:
Calculate ingested dose in mg/kg to work out if significant ingestion:
NAC treatment required
Start or continue NAC if any of the following are true (if possible, within 8h of ingestion):
(N.B. The level of detection of paracetamol is 10 mg/L.)
N.B. If the patient has biochemical tests suggesting acute liver injury (e.g. ALT above the upper limit of normal) give acetylcysteine even if the plasma paracetamol concentration is below the at risk line on the nomogram. In cases of severe poisoning the ALT rises rapidly and is commonly abnormal at first presentation to hospital. A raised ALT may also indicate that the overdose was taken earlier than suggested by the history. Patients with a chronically elevated ALT (e.g. chronic liver disease) may not require acetylcysteine treatment if the ALT and INR have not significantly changed from previously documented values. These cases should be discussed with the NPIS.
Enhanced elimination using renal replacement therapy may be indicated in addition to acetylcysteine if a patient has very high paracetamol concentrations (greater than 700 mg/L) associated with coma and elevated blood lactate concentrations. Intermittent HD is the preferred modality for enhanced elimination. Continuous renal replacement modalities are valid alternatives if intermittent HD is not available. For patients on renal replacement therapy the dose of acetylcysteine (both regimens) should be doubled.
NAC treatment not required
NAC is not required or can be discontinued if:
N-Acetylcysteine (NAC) ampoules contain 2 g NAC in 10 mL (200 mg/mL).
The NAC regime consists of 3 infusions given consecutively over 21 h:
Infusion | NAC dose | Infusion fluid | Duration |
---|---|---|---|
1 | 150 mg/kg | 200 mL | 1 h |
2 | 50 mg/kg | 500 mL | 4 h |
3 | 100 mg/kg | 1000 mL | 16 h |
Re-check the INR, plasma creatinine and ALT at, or just before, the end of the 21 hours of infusion. Paracetamol concentration should only be re-checked at the end of the 21 hour infusion if a large overdose was ingested. If re-checked continue NAC therapy if the paracetamol concentration is above the therapeutic range i.e. 20 mg/L or more. In patients with severe liver toxicity, also check lactate, venous pH or plasma bicarbonate.
Acetylcysteine treatment may be stopped if the blood results meet the following criteria:
Acetylcysteine should be continued if blood results are abnormal and meet ANY of the following criteria:
If acetylcysteine is to be continued, continue at the dose and infusion rate used in the 3rd treatment bag. It is not necessary to give a further loading dose unless a second overdose has been taken. Repeat all blood tests in a further 8-16 hours.
The Scottish and Newcastle Acetylcysteine Protocol (SNAP) regimen for IV acetylcysteine can be used as an alternative to the above.
In all patients re-check the plasma paracetamol concentration, INR, creatinine, venous pH or plasma bicarbonate and ALT at the end of the 2nd treatment bag (12-hour infusion).
If all blood results are normal, the patient can be considered for discharge:
If blood results are abnormal, continue acetylcysteine at the dose and infusion rate used in the 2nd treatment bag:
Clinically significant anaphylactoid reactions to intravenous acetylcysteine occur in up to 30% of patients treated with the standard 21-hour regimen, usually during or soon after the first infusion, when large amounts are given rapidly. They are more common in women, people with asthma or atopy, those with family history of allergies, and patients with low paracetamol levels.
Features may include:
A history of anaphylactoid reactions is NOT a contraindication to intravenous acetylcysteine in patients with paracetamol overdose when antidote treatment is clinically indicated.
Management:
Previous reaction is NOT a contraindication to NAC, but consider pre-treatment with chlorphenamine 10 mg IV, ranitidine 50 mg IV and salbutamol 5 mg neb. Consider using the modified 12-hour IV acetylcysteine regimen (known as the Scottish and Newcastle Acetylcysteine Protocol; SNAP). The total dose of intravenous acetylcysteine is the same as the standard 21-hour regimen (i.e. 300 mg/kg) but the rate and duration of treatment is different which results in a lower peak plasma acetylcysteine concentration and a significantly reduced risk of anaphylactoid reactions.
The King's College Criteria (KCC) are a well-accepted criteria that show the degree of multiorgan dysfunction from paracetamol-induced liver failure. Used alone or with serum lactate and phosphate, the KCC can predict patients with poor prognosis, and select patients most likely to benefit from immediate liver transplant referral.
+/-
Is there something wrong with this question? Let us know and we’ll fix it as soon as possible.
Biochemistry | Normal Value |
---|---|
Sodium | 135 – 145 mmol/l |
Potassium | 3.0 – 4.5 mmol/l |
Urea | 2.5 – 7.5 mmol/l |
Glucose | 3.5 – 5.0 mmol/l |
Creatinine | 35 – 135 μmol/l |
Alanine Aminotransferase (ALT) | 5 – 35 U/l |
Gamma-glutamyl Transferase (GGT) | < 65 U/l |
Alkaline Phosphatase (ALP) | 30 – 135 U/l |
Aspartate Aminotransferase (AST) | < 40 U/l |
Total Protein | 60 – 80 g/l |
Albumin | 35 – 50 g/l |
Globulin | 2.4 – 3.5 g/dl |
Amylase | < 70 U/l |
Total Bilirubin | 3 – 17 μmol/l |
Calcium | 2.1 – 2.5 mmol/l |
Chloride | 95 – 105 mmol/l |
Phosphate | 0.8 – 1.4 mmol/l |
Haematology | Normal Value |
---|---|
Haemoglobin | 11.5 – 16.6 g/dl |
White Blood Cells | 4.0 – 11.0 x 109/l |
Platelets | 150 – 450 x 109/l |
MCV | 80 – 96 fl |
MCHC | 32 – 36 g/dl |
Neutrophils | 2.0 – 7.5 x 109/l |
Lymphocytes | 1.5 – 4.0 x 109/l |
Monocytes | 0.3 – 1.0 x 109/l |
Eosinophils | 0.1 – 0.5 x 109/l |
Basophils | < 0.2 x 109/l |
Reticulocytes | < 2% |
Haematocrit | 0.35 – 0.49 |
Red Cell Distribution Width | 11 – 15% |
Blood Gases | Normal Value |
---|---|
pH | 7.35 – 7.45 |
pO2 | 11 – 14 kPa |
pCO2 | 4.5 – 6.0 kPa |
Base Excess | -2 – +2 mmol/l |
Bicarbonate | 24 – 30 mmol/l |
Lactate | < 2 mmol/l |